Company Information

Shionogi Inc.

Member Type

Associate

Organization Type

Manufacturer

Description

Shionogi Inc. is a U.S. subsidiary of Shionogi & Co., Ltd., a global research driven pharmaceutical company committed to bringing to market the best possible medicines to aid the health and well-being of the patients we serve. Our global expertise in infectious disease began in the 1950s and in addition to discovering and developing multiple innovative antibiotics, today our global portfolio includes an antibiotic for the treatment of serious Gram negative bacterial infections, antivirals for COVID-19, HIV and influenza and a therapeutic for rare fungal infections. Our U.S. infectious disease franchise includes both approved and investigational novel anti-infectives, and investigational antivirals for COVID-19 and RSV. In parallel, we are advancing a U.S. rare disease franchise that includes an approved therapy for amyotrophic lateral sclerosis (ALS), along with clinical programs in Fragile X syndrome, Jordan’s syndrome, and Pompe disease. We are also pursuing research in additional high need therapeutic areas, including oncology, acute ischemic stroke, sleep apnea, and other quality of life areas. Learn more at shionogi.com.

Contact Information

400 Campus Drive

Florham Park, NJ 07932

https://www.shionogi.com/us/en/

(973)966-6900

Services Offered

Branded

Staff

• Banks, Meredith

  Trade Affairs Associate, Shionogi Inc.

• Bennett, David

  Director, IT, Shionogi Inc.

• Cooper, Vince

  Executive Director, Head of Trade Relations and Patient Services, Shionogi Inc.

• Dickson, Pete

  Senior Director, Market Access, Shionogi Inc.

• Frost, Timothy

  Senior Compliance Associate, Shionogi Inc.

• Ginsburg, Lynn

  Office Manager, Shionogi Inc.

• Grant, Sean

  QA Product Specialist, Shionogi Inc.

• Griffin, James

  Supplier Manager, Shionogi Inc.

• Hara, Tadashi

  Executive Vice President and Chief Financial Officer, Shionogi Inc.

• Keith, Jim

  Director, Trade Relations, Shionogi Inc.